Kymera Therapeutics, Inc.KYMRNASDAQ
LOADING
|||
Operating Income Contraction
Trending lower, below historical average, strong compound growth.
Left:
||||
Profit from core business operations before interest and taxes
Latest
$-261.63M
↓ 129% below average
Average (6y)
$-114.13M
Historical baseline
Range
High:$-21.45M
Low:$-261.63M
CAGR
+51.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-261.63M | -58.1% |
| 2023 | $-165.53M | -2.7% |
| 2022 | $-161.26M | -60.4% |
| 2021 | $-100.53M | -117.1% |
| 2020 | $-46.30M | -9.7% |
| 2019 | $-42.20M | -96.8% |
| 2018 | $-21.45M | - |